EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)

Complife

Status: Completed

Conditions: Oxidative Stress

Treatments: Other: Placebo; Dietary Supplement: Immusystem

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT04912947

EVAANIS

Details and patient eligibility

About

The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy adult subjects with high baseline levels of oxidative stress.

Enrollment: 60 patients

Sex: All

Ages: 30 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Caucasian ethnicity;
• Age between 30 and 65 years;
• Smokers who have smoked at least 100 cigarettes in their lifetime and smoke at least 10 cigarettes a day;
• Sportsmen who have been playing sports for at least 6 months between 4 and 8 hours per week;
• Signature of informed consent.

Exclusion criteria

• Systemic pathologies;
• Active drug therapy;
• Estrogen-progestogen therapy;
• Pregnancy;
• Allergies to the components of the raw material under study.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups, including a placebo group

Dietary supplement

Active Comparator group

Description:

One cp/day of the IMMUSYSTEM food supplement for 3 months

Treatment:

Dietary Supplement: Immusystem

Placebo

Placebo Comparator group

Description:

One cp/day of Placebo for 3 months

Treatment:

Other: Placebo